Frontlight ResearchEarly access
Trial site
Headache Center of Hope
- 4running trials
The trials here
What the 4 trials at this site are about, from their registry records.
- Conditions
- Migraine4 trials
- Phase
- Phase 34 trials
- Status
- Active, not recruiting3 trials
- Recruiting1 trial
- Lead sponsor
- Ipsen2 trials
- Eli Lilly and Company1 trial
- TriGemX Bio, Inc.1 trial
Running trials
Recruiting
A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Migraine1 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026